Overview
Nils Deventer practices practicing medicine in Muenster, Germany.
His clinical expertise encompasses Chondroblastoma, Osteosarcoma, Bone Tumor, and Liver Embolization.
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nils Deventer
Is Nils Deventer a top-rated expert for Chondroblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Nils Deventer is classified as an Experienced expert for Chondroblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nils Deventer participate in research or clinical trials?
Yes. Nils Deventer has published 10 articles and abstracts on conditions like Chondroblastoma. You can view a list of Nils Deventer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorMr. Deventer isExperienced. Learn about Bone Tumor.
- ChondroblastomaMr. Deventer isExperienced. Learn about Chondroblastoma.
- Liver EmbolizationMr. Deventer isExperienced. Learn about Liver Embolization.
- OsteosarcomaMr. Deventer isExperienced. Learn about Osteosarcoma.